Could CAR-T Therapy Be an Option for You? Eligibility Criteria Explained

In this video, we break down CAR-T therapy eligibility criteria, including when CAR-T is used in the myeloma treatment journey, required prior therapies, disease status, and key patient factors such as age, performance status, and organ function. CAR-T cell therapy has transformed outcomes for patients with relapsed or refractory multiple myeloma, but not every patient qualifies right away. Learn how FDA approvals, clinical trial data, and real-world practice influence who can receive CAR-T, when referral should happen, and how eligibility may continue to expand. #Myeloma #CARTtherapy #MultipleMyeloma #CancerTreatment #Immunotherapy #MyelomaCare #Hematology #CancerEducation If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/6286... For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.